These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 26353774)

  • 1. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.
    Forte D; Ciciarello M; Valerii MC; De Fazio L; Cavazza E; Giordano R; Parazzi V; Lazzari L; Laureti S; Rizzello F; Cavo M; Curti A; Lemoli RM; Spisni E; Catani L
    Stem Cell Res Ther; 2015 Sep; 6(1):170. PubMed ID: 26353774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
    Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
    Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis.
    Legaki E; Roubelakis MG; Theodoropoulos GE; Lazaris A; Kollia A; Karamanolis G; Marinos E; Gazouli M
    Stem Cell Rev Rep; 2016 Oct; 12(5):604-612. PubMed ID: 27503204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis.
    Molendijk I; Barnhoorn MC; de Jonge-Muller ES; Mieremet-Ooms MA; van der Reijden JJ; van der Helm D; Hommes DW; van der Meulen-de Jong AE; Verspaget HW
    J Crohns Colitis; 2016 Aug; 10(8):953-64. PubMed ID: 26896084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis.
    Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H
    Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
    Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
    Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis.
    Pouya S; Heidari M; Baghaei K; Asadzadeh Aghdaei H; Moradi A; Namaki S; Zali MR; Hashemi SM
    Int Immunopharmacol; 2018 Jan; 54():86-94. PubMed ID: 29112894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells.
    Kawata Y; Tsuchiya A; Seino S; Watanabe Y; Kojima Y; Ikarashi S; Tominaga K; Yokoyama J; Yamagiwa S; Terai S
    Cell Tissue Res; 2019 May; 376(2):257-271. PubMed ID: 30635774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
    Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
    Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.
    Stavely R; Robinson AM; Miller S; Boyd R; Sakkal S; Nurgali K
    Stem Cell Res Ther; 2015 Dec; 6():263. PubMed ID: 26718461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L
    Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
    Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
    Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model.
    Fuenzalida P; Kurte M; Fernández-O'ryan C; Ibañez C; Gauthier-Abeliuk M; Vega-Letter AM; Gonzalez P; Irarrázabal C; Quezada N; Figueroa F; Carrión F
    Cytotherapy; 2016 May; 18(5):630-41. PubMed ID: 27059200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice.
    Wang WQ; Dong K; Zhou L; Jiao GH; Zhu CZ; Li WW; Yu G; Wu WT; Chen S; Sun ZN; Wang YM; Liu WT; Zhang J; Wang BM; Feng XM
    Acta Pharmacol Sin; 2015 Nov; 36(11):1377-87. PubMed ID: 26190499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cell therapy for Crohn's disease.
    Liew A; O'Brien T; Egan L
    Dig Dis; 2014; 32 Suppl 1():50-60. PubMed ID: 25531353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis.
    Li L; Liu S; Xu Y; Zhang A; Jiang J; Tan W; Xing J; Feng G; Liu H; Huo F; Tang Q; Gu Z
    Pharmacology; 2013; 92(5-6):257-64. PubMed ID: 24280970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.